Early disseminated Lyme disease occurs days to weeks after an untreated tick bite as Borrelia burgdorferi disseminates hematogenously, affecting approximately 60% of untreated patients. [1] The hallmark manifestations involve the skin (multiple erythema migrans), nervous system (10–15%), and heart (1–2%). [1-2]
The following figure illustrates the spectrum of erythema migrans presentations, including disseminated lesions (Panel C): [3]
1. History
- Tick exposure: Ask about outdoor activities, endemic area residence/travel (Northeast, Upper Midwest, mid-Atlantic), known tick bite, and timing relative to symptom onset [1][4]
- Initial rash: Prior single EM lesion that may have gone unnoticed or untreated; now new rashes at distant sites
- Symptom timeline: Onset typically weeks after tick bite; neurologic and cardiac manifestations usually within weeks to ~2 months [2]
- Symptom characterization: Fever, chills, malaise, fatigue, headache, myalgias, arthralgias, neck stiffness, facial weakness, palpitations, chest pain, syncope, radicular pain [1][5]
- Important negatives: No joint swelling (suggests late disease), no chronic cognitive decline, no prior antibiotic treatment for Lyme
2. Alarm Features
- Syncope, presyncope, or new-onset bradycardia → Lyme carditis with high-degree AV block (can be fatal) [6-7]
- Bilateral facial palsy → highly suggestive of Lyme neuroborreliosis [1]
- Severe headache with neck stiffness → lymphocytic meningitis
- Rapidly fluctuating heart block — characteristic of Lyme carditis; PR interval >300 ms warrants admission [8]
- Dyspnea, exercise intolerance, pericarditic chest pain → myopericarditis [6]
- Radicular pain with motor weakness → radiculoneuritis requiring IV antibiotics if meningitis is present [4]
3. Medications
Treatment by manifestation (per IDSA/AAN/ACR 2020 Guidelines): [4][6]
- Multiple EM (no neuro/cardiac involvement):
- Doxycycline 100 mg PO BID × 10 days (preferred) [8]
- Amoxicillin 500 mg PO TID × 14 days
- Cefuroxime axetil 500 mg PO BID × 14 days
- Cranial nerve palsy without meningitis: Oral doxycycline 100 mg BID × 14–21 days [2][4]
- Lyme meningitis / CNS involvement: Ceftriaxone 2 g IV daily × 14–21 days (preferred); oral doxycycline 200 mg/day is an alternative for ambulatory patients [2][4]
- Lyme carditis: Initial IV ceftriaxone if hospitalized; transition to oral agents for total 14–21 days [4][6]
- Second-line: Azithromycin (only for EM, not extracutaneous disease; lower efficacy) [1][6]
- Contraindicated: Doxycycline in pregnancy and children <8 years (use amoxicillin or cefuroxime) [1]
- Corticosteroids: Not routinely recommended for Lyme-associated facial palsy [6]
- Avoid: Temporary pacemaker placement should be avoided if possible in Lyme carditis, as conduction abnormalities typically resolve with antibiotics [6]
4. Diet
- No specific dietary triggers or restrictions
- Ensure adequate hydration, especially if febrile
- Patients on doxycycline should avoid dairy products within 2 hours of dosing and take with food/water to reduce GI side effects; avoid prolonged sun exposure (photosensitivity)
5. Review of Systems
- Neuro: Headache, neck stiffness, facial droop (unilateral or bilateral), radicular pain, paresthesias, weakness, cognitive difficulties, photophobia
- Cardiac: Palpitations, chest pain, dyspnea on exertion, syncope/presyncope, exercise intolerance
- MSK: Migratory arthralgias, myalgias, joint swelling (suggests progression to late disease)
- Derm: New rashes at sites distant from original bite
- Constitutional: Fever, chills, night sweats, fatigue, malaise
- Ophthalmologic: Conjunctivitis, visual changes (rare: keratitis, uveitis) [4]
6. Collateral History and Family History
- Confirm tick exposure history from family/companions (patients may not recall a bite — only ~40% of Lyme carditis patients recall EM) [6]
- Household members with similar symptoms (shared tick exposure environment)
- Family history is not a major factor; Lyme disease is not hereditary
- Social context: Occupation (forestry, landscaping, outdoor recreation), pet ownership (dogs can carry ticks indoors), recent camping/hiking
7. Risk Factors
- Geographic: Endemic areas — CT, DE, ME, MD, MA, MN, NH, NJ, NY, PA, RI, VT, VA, WI account for 95% of US cases [4]
- Seasonal: Peak May–September (nymphal Ixodes scapularis activity)
- Outdoor exposure: Hiking, gardening, camping in wooded/grassy areas
- Tick attachment duration: Transmission typically requires ≥36 hours of attachment
- Lyme carditis: Peak incidence in young adult and middle-aged men [6]
- Failure to treat early localized disease is the primary risk factor for dissemination [1]
8. Differential Diagnosis
- Multiple EM mimics: Erythema multiforme, viral exanthem, cellulitis, granuloma annulare, tinea corporis, Southern Tick-Associated Rash Illness (STARI) [1]
- Facial palsy DDx: Idiopathic Bell's palsy (bilateral palsy strongly favors Lyme), stroke, Ramsay Hunt syndrome, sarcoidosis, Guillain-Barré
- Meningitis DDx: Viral meningitis (enterovirus), tuberculous meningitis, fungal meningitis, neurosyphilis, carcinomatous meningitis
- Carditis DDx: Viral myocarditis, acute rheumatic fever, sarcoidosis, idiopathic AV block, acute coronary syndrome
- Co-infections: Anaplasmosis and babesiosis are transmitted by the same tick vector and may co-occur — consider if atypical features (leukopenia, thrombocytopenia, hemolytic anemia) [4]
9. Past Medical History
- Prior Lyme disease episodes (reinfection is possible; prior infection does not confer lasting immunity)
- Pre-existing cardiac conduction disease (complicates interpretation of new AV block)
- Immunocompromised states (may affect serologic response)
- Medication allergies — particularly to doxycycline, penicillins, cephalosporins
- Pregnancy status (affects antibiotic choice)
10. Physical Exam
- Vitals: Bradycardia (Lyme carditis), fever, hypotension (if high-degree block)
- Skin: Multiple annular erythematous lesions distant from original bite site; most are uniformly erythematous rather than classic "bull's-eye" [3]
- Neuro: Cranial nerve exam (especially CN VII — bilateral facial palsy is highly suggestive); motor/sensory exam for radiculopathy; meningeal signs (Kernig, Brudzinski); fundoscopic exam for papilledema (rare pseudotumor cerebri) [1]
- Cardiac: Irregular rhythm, pauses, new murmur, pericardial friction rub, signs of heart failure
- MSK: Joint effusions (especially large joints — knees), tenderness along tendons/bursae
- Lymph nodes: Regional or generalized lymphadenopathy
11. Lab Studies
- Two-tiered serologic testing (primary diagnostic test for disseminated disease): [9]
- First tier: EIA screen
- Second tier: IgM/IgG Western blot (standard) or supplemental EIA (modified two-tiered — improved early sensitivity: 74% vs 41%) [9]
- CBC: Generally normal; leukopenia/thrombocytopenia suggests co-infection with Anaplasmosis or Babesiosis
- CMP/LFTs: Mildly elevated hepatic transaminases may be seen [4]
- ESR/CRP: Often elevated [4]
- Troponin, BNP: If cardiac involvement suspected
- CSF analysis (if meningitis suspected): Lymphocytic pleocytosis, elevated protein, normal glucose; CSF:serum antibody index for CNS involvement [6][8]
- Blood smear: If co-infection with Babesia suspected
12. Imaging
- Chest X-ray: If dyspnea or signs of heart failure; evaluate for cardiomegaly or pericardial effusion
- Echocardiogram: If myopericarditis suspected — assess ventricular function, pericardial effusion
- Brain MRI with contrast: If CNS involvement suspected (encephalitis, myelitis); may show meningeal enhancement or white matter lesions
- Imaging is not routinely needed for isolated multiple EM or isolated facial palsy without CNS symptoms
13. Special Tests
- ECG: Essential in all suspected disseminated Lyme (see ECG section below)
- Lumbar puncture: Indicated if meningitis, encephalitis, or CNS involvement suspected; obtain paired CSF and serum for antibody index [8][10]
- Modified two-tiered testing (MTTTA): Improved sensitivity over standard algorithm in early disease [9]
- IgM Western blot: Only interpretable if symptoms present <30 days [1]
14. ECG
- Obtain ECG on all patients with suspected early disseminated Lyme disease [8]
- Key findings:
- First-degree AV block (PR prolongation) — most common
- Second-degree AV block (Mobitz type I or II)
- Third-degree (complete) heart block — can fluctuate rapidly and is the most dangerous manifestation [6]
- Sinus node dysfunction
- Atrial or ventricular arrhythmias (less common)
- PR interval >300 ms → hospital admission with continuous telemetry [8][10]
- Pearl: AV block in Lyme carditis characteristically fluctuates rapidly — a patient can progress from first-degree to complete heart block within minutes to hours [6]
15. Assessment
Early disseminated Lyme disease represents hematogenous spread of B. burgdorferi occurring days to months after initial infection. The clinical triad of multiple EM, neuroborreliosis, and carditis defines this stage. [1-2] Approximately 10–15% of untreated patients develop neurologic involvement and 1–2% develop cardiac involvement. [2] Severity stratification depends on the organ system involved:
- Mild: Multiple EM without systemic toxicity → outpatient oral antibiotics
- Moderate: Isolated cranial nerve palsy without meningitis → outpatient oral antibiotics with close follow-up
- Severe: Lyme meningitis, high-degree AV block, myopericarditis → hospitalization and IV antibiotics
Atypical presentations include vesicular EM lesions, isolated radiculopathy, and pseudotumor cerebri. [1][4] Approximately 10% of treated patients experience persistent symptoms (post-treatment Lyme disease syndrome), though prolonged antibiotics are not beneficial. [11-12]
16. Treatment Plan
Initial stabilization (ED)
- ABCs; IV access if hemodynamically unstable
- Atropine or transcutaneous pacing for symptomatic high-degree AV block (avoid permanent pacemaker — block typically resolves with antibiotics) [6]
- Initiate antibiotics promptly
Antibiotic regimens: [2][4][6]
Supportive care
- Ophthalmologic protection for facial palsy (lubricating drops, taping eye shut at night)
- NSAIDs for pain/fever
- Cardiac monitoring for carditis patients
17. Disposition
Admit: [8][10]
- PR interval >300 ms or high-degree AV block
- Symptomatic bradycardia, syncope, or hemodynamic instability
- Myopericarditis with ventricular dysfunction or pericardial effusion
- Lyme meningitis requiring IV antibiotics
- Inability to tolerate oral medications
Discharge
- Multiple EM without cardiac or neurologic involvement
- Isolated facial palsy without meningitis (confirmed by LP or low clinical suspicion for CNS disease)
- Mild first-degree AV block (PR <300 ms) with close cardiology follow-up
Observation
- Borderline PR prolongation (approaching 300 ms) with telemetry monitoring
- Facial palsy with pending LP results
Consult triggers: Cardiology (any conduction abnormality), Neurology (meningitis, encephalitis, radiculopathy), Infectious Disease (atypical presentations, treatment failure, co-infections)
18. Follow Up / Return Precautions
- Follow-up timing: 2–4 weeks after treatment initiation; repeat ECG if carditis was present (conduction abnormalities typically resolve within 1–2 weeks) [6]
- Facial palsy: Most resolve within weeks to months; if no improvement by 6–8 weeks, reassess diagnosis
- Return immediately for: Syncope, presyncope, worsening palpitations, new neurologic deficits, worsening headache, high fever, shortness of breath, chest pain
- Patient counseling:
- Antibiotic treatment is highly effective; most patients recover fully [11]
- ~10% may experience persistent fatigue, pain, or cognitive symptoms after treatment (post-treatment Lyme disease syndrome) — these typically improve over time; prolonged antibiotics are not beneficial [11-12]
- Tick prevention education: DEET-based repellents, permethrin-treated clothing, daily tick checks, prompt removal
- Reinfection is possible — prior infection does not confer lasting immunity
- Expected recovery: EM lesions resolve within days to weeks of treatment; facial palsy recovery may take weeks to months; cardiac conduction abnormalities typically resolve within 1–2 weeks [6]
References
1. Tickborne Diseases of the United States: A Reference Manual for Healthcare Providers Sixth Edition. — Nancy Shadick MD MPH, Nancy Maher MPH, Dennis Hoak MD United States Centers for Disease Control and Prevention (2022). 2022.
2. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. — Sanchez E, Vannier E, Wormser GP, Hu LT. The Journal of the American Medical Association. 2016.
3. Lyme Disease. — Shapiro ED. The New England Journal of Medicine. 2014.
4. Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Management of Tick-Borne Illness in the United States. — Ho BM, Davis HE, Forrester JD, et al. Wilderness & Environmental Medicine. 2021.
5. Lyme disease. — National Library of Medicine (MedlinePlus) 2018.
6. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2021.
7. Incidence of Carditis and Predictors of Pacemaker Implantation in Patients Hospitalized With Lyme Disease. — Uzomah UA, Rozen G, Mohammadreza Hosseini S, et al. PloS One. 2021.
8. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Arthritis & Rheumatology. 2021.
9. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
10. Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Neurology. 2021.
11. Lyme Borreliosis. — Strle F, Strle K, Marques A, et al. Nature Reviews. Disease Primers. 2026.
12. Lyme Borreliosis: Diagnosis and Management. — Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. BMJ. 2020.